通过孟德尔的随机化分析识别糖尿病多神经病的潜在药物标
Xiaokun Chen1, Guohua Jiang2,3, Tianjing Zhao2,3
1Department of Orthopaedic Surgery, Shanghai Ninth People's Hospital, Shanghai, China.
Cell & bioscience
|December 5, 2024
概括
这项研究使用了门德尔随机化来发现与糖尿病多神经病 (DPN) 风险相关的96种血蛋白. 这些蛋白质,包括ITM2B,为DPN药物开发提供了新的治疗点.
科学领域:
- 遗传学 是一个遗传学.
- 蛋白质组学是指蛋白质组学.
- 代谢疾病 代谢疾病
背景情况:
- 糖尿病多神经病 (DPN) 是糖尿病的常见并发症,治疗选择很少.
- 确定新的治疗点对于管理DPN至关重要.
- 门德尔随机化 (MR) 是一种强大的遗传方法,用于推断因果关系.
研究的目的:
- 确定循环中的血蛋白作为DPN的潜在治疗点.
- 调查基因决定的血蛋白水平与DPN风险之间的因果关系.
主要方法:
- 利用了来自七项全基因组关联研究 (GWAS) 的蛋白质定量特征位点 (pQTLs).
- 采用两样 MR (MR-Egger,反变量加权) 与来自 IEU OpenGWAS 项目的 DPN 数据.
- 使用科克兰的Q测试和I2统计数据验证的结果.
主要成果:
- 使用cis-pQTLs确定了62种与DPN相关的蛋白质 (33种增加风险,29种降低风险).
- 使用cis-pQTLs + trans-pQTLs (44增加风险,72降低风险) 确定了116种与DPN相关的蛋白质.
- 施泰格定向性测试证实了血蛋白和DPN风险之间的因果关系.
结论:
- 确定了96种循环等离子体蛋白质,其基因决定的水平影响了DPN风险.
- 这些蛋白质代表了DPN药物开发的新型潜在点.
- 特定的蛋白质如ITM2B,CREG1,CD14和PLXNA4被突出显示为有前途的标.
相关概念视频
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
159
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
159
01:29Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
01:28Diabetic Nephropathy
32
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
32
01:22Diabetic Neuropathy
59
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
59